June 29, 2017

A whistleblower will receive an award of $488,700 from the $2.7 million to be paid by Innovative Therapies, Inc. and its parent company Cardinal Health, Inc. to settle charges they violated the False Claims Act by submitting false claims to Medicare through their marketing of certain negative pressure wound treatment devices as durable medical equipment when they knew these devices did not have the expected life of a durable device.  DOJ (MDTN)

Tagged in: FCA Federal, Whistleblower Case,